SNY - Sanofi

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
43.85
-0.30 (-0.68%)
As of 2:14PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close44.15
Open43.91
Bid43.80 x 900
Ask43.82 x 1100
Day's Range43.79 - 43.98
52 Week Range39.48 - 45.62
Volume420,519
Avg. Volume1,356,669
Market Cap108.01B
Beta (3Y Monthly)0.40
PE Ratio (TTM)22.60
EPS (TTM)1.94
Earnings DateN/A
Forward Dividend & Yield1.74 (3.94%)
Ex-Dividend Date2019-05-07
1y Target Est52.00
Trade prices are not sourced from all markets
  • This would be the worst-case scenario for health stocks, according to UBS
    MarketWatch2 days ago

    This would be the worst-case scenario for health stocks, according to UBS

    Health-care reform is coming, UBS analysts say, and it could have severe consequences for health companies.

  • Regeneron And Sanofi Tried To Outperform Themselves — And Couldn't
    Investor's Business Daily3 days ago

    Regeneron And Sanofi Tried To Outperform Themselves — And Couldn't

    AnaptysBio stock tumbled Friday after the results of a study from Regeneron Pharmaceuticals and Sanofi cast doubt on the biotech company's ability to compete in asthma treatment.

  • Sanofi/Regeneron's Asthma Candidate Meets Goal in Study
    Zacks3 days ago

    Sanofi/Regeneron's Asthma Candidate Meets Goal in Study

    Sanofi/Regeneron's IL-33 antibody REGN3500 meets primary endpoint in phase II study in asthma. It does not show increased benefit compared to Dupixent.

  • Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod
    Zacks3 days ago

    Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod

    Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.

  • Benzinga3 days ago

    The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals ...

  • The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens
    Zacks4 days ago

    The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens

    The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens

  • Here’s What Hedge Funds Think About Sanofi (SNY)
    Insider Monkey4 days ago

    Here’s What Hedge Funds Think About Sanofi (SNY)

    The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 delivered very strong gains as a result, with the Russell 2000, which is composed of smaller companies, outperforming the large-cap stocks slightly during the first quarter. Unfortunately sentiment shifted […]

  • Sanofi plans 466 job cuts as part of R&D reshuffle
    Reuters5 days ago

    Sanofi plans 466 job cuts as part of R&D reshuffle

    Sanofi on Wednesday said a reorganisation of its research and development operation in Germany and France would result in 466 job cuts in the two countries. In an emailed statement, a spokesman with the French drugmaker said the reshuffle aimed at enabling Sanofi to concentrate its research efforts in cancer, immunology, rare diseases and vaccines. The 466 job cuts are to be implemented on a voluntary basis, Sanofi said.

  • Alphabet's Healthcare Push Gains Steam: Others Brace Up
    Zacks5 days ago

    Alphabet's Healthcare Push Gains Steam: Others Brace Up

    Alphabet's (GOOGL) Google's partnership with Sanofi provides it a competitive edge in the healthcare sector.

  • Benzinga6 days ago

    Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab

    Sanofi SA (NASDAQ: SNY ) and Alphabet Inc (NASDAQ: GOOG ) (NASDAQ: GOOGL ) said Tuesday they have joined forces to launch a virtual Innovation lab with the aim of transforming how medicine and health services ...

  • Sanofi Partners Google to Build Healthcare Innovation Lab
    Zacks6 days ago

    Sanofi Partners Google to Build Healthcare Innovation Lab

    Sanofi (SNY) signs a partnership pact with Google to develop a new virtual healthcare innovation lab for modernizing future medicines and healthcare services with sophisticated data technologies.

  • Protalix (PLX) Completes Enrollment in Fabry Disease Study
    Zacks6 days ago

    Protalix (PLX) Completes Enrollment in Fabry Disease Study

    Protalix (PLX) closes enrollment in the late-stage study on PRX-102, currently being developed for the treatment of patients with Fabry disease.

  • Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients
    Zacks6 days ago

    Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients

    Novo Nordisk's (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.

  • Market Exclusive6 days ago

    Market Morning: Trump Immigrant Roundup, Gold Threatens, Google Goes Pharma

    Trump Promises Mass Roundup of Millions of Undocumented Immigrants The low-end of the US economy could be on the verge of a serious conflagration. United States President Donald Trump has promised, via tweet as is his wont, that ICE agents will start “removing the millions of illegal aliens who have illicitly found their way into […]The post Market Morning: Trump Immigrant Roundup, Gold Threatens, Google Goes Pharma appeared first on Market Exclusive.

  • French drugmaker Sanofi, Google to use data tech for innovations
    Reuters6 days ago

    French drugmaker Sanofi, Google to use data tech for innovations

    French healthcare company Sanofi has teamed up with Google to work on innovations, aimed at using emerging data technologies to change how medicines and health services will be delivered in future. Sanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in a joint statement. "Combining Sanofi's biologic innovations and scientific data with Google's industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies," said Ameet Nathwani, chief medical officer and executive vice-president, Sanofi.

  • Google and Drugmaker Sanofi to Join Forces on Data Technologies
    Bloomberg6 days ago

    Google and Drugmaker Sanofi to Join Forces on Data Technologies

    (Bloomberg) -- Alphabet Inc.’s Google will bring its artificial-intelligence and cloud-computing capabilities to a new partnership with pharma giant Sanofi.The project is aimed at accelerating the discovery of new medicines, increasing the understanding of what treatments work for patients and making Sanofi’s operations more efficient, the Paris-based drugmaker said in a statement Tuesday. The companies didn’t provide financial details.The pact is the latest sign of increasing collaboration between the technology and health-care industries. Pharma companies like Sanofi are teaming up with AI specialists, hiring data scientists or even snapping up tech startups in a bid to become faster and more efficient as costs rise.The new partnership will allow Sanofi to come up with more personalized approaches to treatment, the company said. The drugmaker and Google also plan to apply artificial intelligence to forecast sales and improve marketing and supply efforts.To contact the reporter on this story: James Paton in London at jpaton4@bloomberg.netTo contact the editors responsible for this story: Eric Pfanner at epfanner1@bloomberg.net, Timothy AnnettFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Financial Times6 days ago

    Sanofi/Google: pixel of health

    Healthcare was slow to benefit from digitalisation. Heavy regulations, pricing power and a history of failed IT projects were to blame. Tuesday’s tie-up between Google and French drugmaker Sanofi to create a “virtual innovation lab” is the latest example.

  • Regeneron (REGN) Presents Positive Data on Lymphoma Candidate
    Zacks7 days ago

    Regeneron (REGN) Presents Positive Data on Lymphoma Candidate

    Regeneron (REGN) reports positive early-stage data on REGN1979 in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma.

  • Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
    Zacks10 days ago

    Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod

    Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.

  • Does Sanofi (EPA:SAN) Create Value For Shareholders?
    Simply Wall St.11 days ago

    Does Sanofi (EPA:SAN) Create Value For Shareholders?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Lilly Announces Tradjenta Cardiovascular Outcome Study Data
    Zacks13 days ago

    Lilly Announces Tradjenta Cardiovascular Outcome Study Data

    Tradjenta leads to fewer events of hypoglycemia and modest weight reduction in type II diabetes patients compared to Sanofi's Amaryl.

  • CNW Group13 days ago

    Canadian employers underestimate the presence of chronic disease in the workforce

    TORONTO , June 11, 2019 /CNW Telbec/ - The 22nd edition of The Sanofi Canada Healthcare Survey uncovered gaps in knowledge that can serve to help guide decision-making among employers who provide health benefit plans to employees. A persistent gap is employers' underestimation of the presence of chronic disease in their workforce, which suggests they may also underestimate the negative impact of unmanaged disease on productivity.

  • Sanofi (SNY) in Focus: Stock Moves 5.5% Higher
    Zacks14 days ago

    Sanofi (SNY) in Focus: Stock Moves 5.5% Higher

    Sanofi (SNY) shares rose nearly 6% in the last trading session, amid huge volumes.

  • Benzinga17 days ago

    Sanofi's Leadership Transition: What You Need To Know

    With big pharma companies grappling with fundamental as well as geopolitical issues — including aging pipelines, key blockbuster drugs going off patent and a U.S. clampdown on drug pricing — many have turned to new leadership in recent years to reinvigorate growth. Sanofi has a mandatory 65-year-old retirement age for its CEO.